NASDAQ · ECORHealthcareElectromedical Equipment

electroCore financials

$10.88−1.36%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
FY19
Dec 31
FY18
Dec 31
Revenue$32.0M$25.2M$16.0M$8.6M$5.5M$3.5M$2.4M$993.0K
Gross profit$27.8M$21.4M$13.2M$7.0M$4.1M$1.8M$1.2M$414.2K
Gross margin86.8%85.0%82.5%81.2%74.6%50.3%51.6%41.7%
Operating income-$13.2M-$12.2M-$19.3M-$22.9M-$20.0M-$24.7M-$46.1M-$54.6M
Net income-$14.0M-$11.9M-$18.8M-$22.2M-$17.2M-$23.5M-$45.1M-$34.7M
Net margin−43.6%−47.2%−117.5%−257.9%−315.9%−672.5%−1888.8%−3494.8%
Diluted EPS$-1.65$-1.59$-3.42$-4.69$-4.36$-9.00$-23.10$-17.85
EBITDA-$12.7M-$11.4M-$18.3M-$22.3M-$19.7M-$23.3M-$43.8M-$54.5M
Operating cash flow-$8.2M-$6.9M-$14.7M-$16.6M-$13.6M-$20.1M-$45.1M-$47.1M
Free cash flow-$8.3M-$6.9M-$14.9M-$16.6M——-$45.1M-$47.4M
Diluted shares8.5M7.5M5.5M4.7M3.9M2.6M2.0M2.0M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$7.0M$3.7M$10.3M$17.7M$34.7M$4.2M
Short-term investments$4.6M$8.5M$0.00$0.00—$18.4M
Total debt$6.6M$0.00$0.00$0.00$0.00$1.4M
Total assets$18.7M$20.5M$16.1M$24.8M$42.8M$31.5M
Total liabilities$20.4M$12.9M$8.7M$7.7M$6.2M$7.9M
Shareholders' equity-$1.7M$7.5M$7.4M$17.1M$36.6M$23.6M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology